Monte Rosa Therapeutics (GLUE) Cash flow

382 Followers

Monte Rosa Therapeutics Cash Flow

GLUE's free cash flow for Q4 2025 was $-43.78M. For the 2025 fiscal year, GLUE's free cash flow was decreased by $-65.51M and operating cash flow was $-43.01M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -22.80M	$ 42.00M	$ -43.80M	$ -92.47M	$ -59.36M
Investing Cash Flow	$ -101.83M	$ -44.45M	$ 88.80M	$ -219.22M	$ -9.65M
Financing Cash Flow	$ 30.35M	$ 98.89M	$ 27.49M	$ 20.47M	$ 377.56M
End Cash Position	$ 134.84M	$ 229.12M	$ 132.68M	$ 60.19M	$ 351.41M
Free Cash Flow	$ -27.50M	$ 38.01M	$ -62.84M	$ -105.38M	$ -69.09M

Currency in USD